10x Genomics (MEX:TXG) EPS (Basic): MXN-2.91 (TTM As of Mar. 2026)


MEX:TXG 10x Genomics Inc MEX:TXG
68 GF Score
Price MXN335.54
GF Value MXN200.14
! 8 Warning Signs
View Full Analysis

What is 10x Genomics EPS (Basic)?

10x Genomics MEX:TXG 68 EPS (Basic) is MXN-2.91 as of Mar. 2026. GuruFocus rates MEX:TXG with a GF Score™ of 68/100 and a GF Value™ of MXN200.14. The stock has 8 warning signs investors should review.

10x Genomics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was MXN-1.80. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-2.91.

10x Genomics's EPS (Diluted) for the three months ended in Mar. 2026 was MXN-1.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-2.91.

10x Genomics's EPS without NRI for the three months ended in Mar. 2026 was MXN-1.80. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -8.69.

During the past 3 years, the average EPS without NRI Growth Rate was 23.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, 10x Genomics's highest 3-Year average EPS without NRI Growth Rate was 23.00% per year. The lowest was -110.90% per year. And the median was -11.75% per year.

10x Genomics  (MEX:TXG) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

10x Genomics EPS (Basic) Related Terms

10x Genomics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for 10x Genomics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics EPS (Basic) Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -10.87 -28.46 -37.00 -31.70 -6.30

10x Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.73 5.27 -4.04 -2.34 -1.80
MEX:TXG
68GF Score
10x Genomics Inc MEX:TXG
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

10x Genomics's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-784.04-0)/124.750
=-6.28

10x Genomics's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-242.9-0)/128.291
=-1.89

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of MXN-2.91 mean?
10x Genomics (MEX:TXG) has a EPS (Basic) of MXN-2.91 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on 10x Genomics and its competitors.
Is 10x Genomics' EPS (Basic) too high?
10x Genomics' current EPS (Basic) is MXN-2.91. Overall, 10x Genomics has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' EPS (Basic) compare to WAY and DOCS?
10x Genomics' EPS (Basic) of MXN-2.91 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on 10x Genomics and its competitors. 10x Genomics's current EPS (Basic) is MXN-2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
10x Genomics (MEX:TXG) has a current EPS (Basic) of MXN-2.91. The stock's GF Value™ is MXN200.14, compared to a current price of MXN335.54 — trading 67.7% above its estimated fair value. The current EPS (Basic) is MXN-2.91. 10x Genomics' overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For 10x Genomics (MEX:TXG), the current EPS (Basic) is MXN-2.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (MEX:TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of MXN335.54 is trading 67.7% above its estimated GF Value™ of MXN200.14.

Key valuation signals for MEX:TXG:

  • EPS (Basic): MXN-2.91
  • GF Value™: MXN200.14 vs. price of MXN335.54 (67.7% above fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
68GF Score

Get the complete analysis for MEX:TXG

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN335.54
Price
MXN200.14
GF Value